Korea Investment Corp’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$36M Buy
449,499
+44,577
+11% +$3.68M 0.07% 251
2025
Q4
$34.5M Sell
404,922
-105,968
-21% -$8.7M 0.07% 254
2025
Q3
$39.7M Buy
510,890
+46,317
+10% +$3.62M 0.08% 231
2025
Q2
$36.3M Sell
464,573
-182,702
-28% -$13.6M 0.08% 238
2025
Q1
$46.9M Buy
647,275
+176,625
+38% +$12.6M 0.11% 172
2024
Q4
$34.8M Buy
470,650
+149,315
+46% +$10.5M 0.08% 226
2024
Q3
$21.2M Sell
321,335
-240,801
-43% -$17.5M 0.05% 328
2024
Q2
$51.9M Buy
562,136
+30,456
+6% +$2.7M 0.13% 143
2024
Q1
$50.8M Buy
531,680
+24,908
+5% +$2.09M 0.13% 164
2023
Q4
$38.6M Buy
506,772
+193,286
+62% +$13.4M 0.1% 218
2023
Q3
$21.7M Sell
313,486
-300,050
-49% -$24.1M 0.06% 291
2023
Q2
$57.9M Sell
613,536
-100,985
-14% -$8.78M 0.16% 143
2023
Q1
$59.1M Buy
714,521
+112,950
+19% +$8.88M 0.17% 140
2022
Q4
$44.9M Buy
601,571
+193,111
+47% +$14.9M 0.14% 170
2022
Q3
$33.8M Sell
408,460
-166,499
-29% -$16M 0.1% 216
2022
Q2
$54.7M Buy
574,959
+188,759
+49% +$19.5M 0.17% 143
2022
Q1
$45.5M Sell
386,200
-178,200
-32% -$20M 0.11% 198
2021
Q4
$73.1M Sell
564,400
-516,000
-48% -$60.2M 0.19% 135
2021
Q3
$122M Buy
1,080,400
+828,800
+329% +$94.6M 0.36% 58
2021
Q2
$26.1M Sell
251,600
-18,800
-7% -$1.77M 0.07% 235
2021
Q1
$22.6M Sell
270,400
-176,500
-39% -$14.9M 0.07% 237
2020
Q4
$40.8M Buy
446,900
+194,000
+77% +$16.1M 0.12% 187
2020
Q3
$20.2M Sell
252,900
-33,900
-12% -$2.65M 0.07% 235
2020
Q2
$19.8M Buy
286,800
+15,000
+6% +$1.07M 0.07% 241
2020
Q1
$17.1M Sell
271,800
-18,765
-6% -$1.35M 0.08% 237
2019
Q4
$22.6M Sell
290,565
-33,600
-10% -$2.62M 0.08% 238
2019
Q3
$23.8M Buy
324,165
+54,300
+20% +$3.81M 0.1% 218
2019
Q2
$16.6M Sell
269,865
-72,300
-21% -$4.37M 0.07% 269
2019
Q1
$21.8M Buy
342,165
+57,048
+20% +$3.26M 0.1% 222
2018
Q4
$14.6M Buy
285,117
+70,800
+33% +$3.58M 0.08% 261
2018
Q3
$12.4M Sell
214,317
-1,036,797
-83% -$50.7M 0.06% 308
2018
Q2
$60.7M Buy
1,251,114
+32,400
+3% +$1.51M 0.28% 91
2018
Q1
$56.7M Buy
1,218,714
+30,765
+3% +$1.34M 0.26% 99
2017
Q4
$44.6M Buy
1,187,949
+120,900
+11% +$4.44M 0.2% 139
2017
Q3
$38.9M Buy
1,067,049
+630,600
+144% +$24.1M 0.18% 139
2017
Q2
$17.2M Buy
436,449
+307,401
+238% +$11.2M 0.08% 241
2017
Q1
$4.05M Buy
129,048
+25,095
+24% +$786K 0.02% 465
2016
Q4
$3.25M Sell
103,953
-235,320
-69% -$7.62M 0.02% 475
2016
Q3
$13.6M Buy
339,273
+128,073
+61% +$4.82M 0.07% 262
2016
Q2
$7.02M Buy
211,200
+75,000
+55% +$2.57M 0.04% 353
2016
Q1
$4M Buy
+136,200
New +$3.76M 0.03% 381
2015
Q4
Sell
-258,000
Closed -$6.11M 649
2015
Q3
$6.11M Buy
258,000
+35,400
+16% +$854K 0.05% 324
2015
Q2
$5.28M Buy
222,600
+168,000
+308% +$3.79M 0.05% 368
2015
Q1
$1.3M Buy
+54,600
New +$1.22M 0.01% 553
2014
Q3
Sell
-208,200
Closed -$2.98M 567
2014
Q2
$2.98M Buy
+208,200
New +$2.82M 0.02% 444
2014
Q1
Sell
-169,800
Closed -$1.86M 617
2013
Q4
$1.86M Sell
169,800
-75,600
-31% -$852K 0.02% 482
2013
Q3
$2.85M Buy
245,400
+100,200
+69% +$1.17M 0.03% 441
2013
Q2
$1.63M Buy
+145,200
New +$1.72M 0.02% 496

Other funds holding EW

Korea Investment Corp's EW Position: Q1 2026 in Review

Korea Investment Corp increased its Edwards Lifesciences (EW) stake by 11% in Q1 2026, buying an estimated $3.68M and bringing the position to 449,499 shares worth $36M. The position accounts for 0.07% of the portfolio, ranked #251.

Korea Investment Corp first reported a position in EW in Q2 2013 and has held it in 48 quarters since. The position peaked at $122M in Q3 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Korea Investment Corp held 449,499 shares of Edwards Lifesciences worth $36M as of Q1 2026.
  • Korea Investment Corp bought 44,577 Edwards Lifesciences shares in Q1 2026, an estimated $3.68M.
  • Edwards Lifesciences made up 0.07% of Korea Investment Corp's portfolio in Q1 2026, its #251 holding.
  • Korea Investment Corp first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 48 quarters since.
  • Korea Investment Corp's Edwards Lifesciences position peaked at $122M in Q3 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Korea Investment Corp's 13F filing for Q1 2026, filed 13 May 2026.